Literature DB >> 11370824

Has desmoplastic response extent protective action against tumor aggressiveness in gastric carcinoma?

A Caporale1, U M Cosenza, A R Vestri, A Giuliani, U Costi, G Galati, C Cannaviello, F Franchi.   

Abstract

A clinical assessment of protective action of desmoplastic response by limiting tumor aggressiveness has been carried out in 171 patients with gastric carcinoma, surgically treated at the First Surgical Clinic of the University of Rome "La Sapienza" between 1988-1999. A univariate statistical analysis was performed using Kaplan-Meier method for: desmoplastic reaction, age, sex, histologic type, tumor size, stage, lymphonodal status and metastases. To determine the influence of these factors on prognosis, the Cox regression was applied. We found a significant association between desmoplastic reaction extent and presence or absence of metastases (p= 0.026), lymphonodal involvement (p = 0.05), stage (p = 0.036). In the univariate analysis, survival was significantly related to sex (p = 0.012), tumor size (p = 0.009), lymphonodal involvement (p = 0.000), metastases (p = 0.000), stage (p = 0.000), desmoplastic reaction extent (p = 0.05); age and histologic type showed no relationship (p = n.s.). The desmoplastic response extent is not a protective factor against tumor invasiveness in gastric carcinoma, on the contrary it may be considered a negative prognostic factor.

Entities:  

Mesh:

Year:  2001        PMID: 11370824

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  6 in total

1.  A comparative analysis of oncofetal fibronectin and tenascin-C incorporation in tumour vessels using human recombinant SIP format antibodies.

Authors:  Alexander Berndt; Robert Köllner; Petra Richter; Marcus Franz; Astrid Voigt; Angela Berndt; Laura Borsi; Raffaella Giavazzi; Dario Neri; Hartwig Kosmehl
Journal:  Histochem Cell Biol       Date:  2010-03-17       Impact factor: 4.304

Review 2.  Strategies for the discovery and development of therapies for metastatic breast cancer.

Authors:  Bedrich L Eckhardt; Prudence A Francis; Belinda S Parker; Robin L Anderson
Journal:  Nat Rev Drug Discov       Date:  2012-06-01       Impact factor: 84.694

3.  Histological factors contributing to a high risk of recurrence of submucosal invasive cancer (pT1) of the colon and rectum after endoscopic therapy.

Authors:  Ichiro Nakada; Takanobu Tabuchi; Takeshi Nakachi; Jiro Shimazaki; Satoru Konishi; Motonobu Katano; Hideyuki Ubukata; Yoshihisa Goto; Yoshinori Watanabe; Takafumi Tabuchi
Journal:  Surg Today       Date:  2008-07-31       Impact factor: 2.549

4.  The increase of MICA gene A9 allele associated with gastric cancer and less schirrous change.

Authors:  S-S Lo; Y-J Lee; C-W Wu; C-J Liu; J-W Huang; W-Y Lui
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640

5.  ERK phosphorylation functions in invadopodia formation in tongue cancer cells in a novel silicate fibre-based 3D cell culture system.

Authors:  Masaharu Noi; Ken-Ichi Mukaisho; Saori Yoshida; Shoko Murakami; Shinya Koshinuma; Takeshi Adachi; Yoshisato Machida; Masashi Yamori; Takahisa Nakayama; Gaku Yamamoto; Hiroyuki Sugihara
Journal:  Int J Oral Sci       Date:  2018-10-22       Impact factor: 6.344

Review 6.  CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion.

Authors:  Gurcan Gunaydin
Journal:  Front Oncol       Date:  2021-07-14       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.